Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 7/20 | 0.42 |
| ▸ | BRD4 | O60885 | 6/20 | 0.42 |
| ▸ | SYK | P43405 | 9/20 | 0.38 |
| ▸ | FPR1 | P21462 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 2/20 | 0.32 |
| ▸ | BTK | Q06187 | 1/20 | 0.32 |
| ▸ | MERTK | Q12866 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | ITK | Q08881 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2446023 | 0.92 | SYK (0.36) | CREBBPBRD4SYKFPR1JAK3 | |
| SCHEMBL2446711 | 0.89 | CREBBP (0.42) | CREBBPBRD4SYK | |
| SCHEMBL2450613 | 0.88 | CREBBP (0.51) | CREBBPBRD4 | |
| SCHEMBL2451064 | 0.84 | CREBBP (0.56) | CREBBPBRD4SYK | |
| SCHEMBL2446331 | 0.83 | CREBBP (0.41) | CREBBPBRD4SYK | |
| SCHEMBL2450149 | 0.82 | CREBBP (0.43) | CREBBPBRD4SYK | |
| SCHEMBL2450583 | 0.81 | CREBBP (0.41) | CREBBPBRD4JAK3 | |
| SCHEMBL2840310 | 0.81 | CREBBP (0.41) | CREBBPBRD4SYK | |
| SCHEMBL2445562 | 0.81 | CREBBP (0.41) | CREBBPBRD4SYK | |
| SCHEMBL2446851 | 0.81 | CREBBP (0.42) | CREBBPBRD4SYKJAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367826-A1 | MODULATORS OF AMYLOID BETA. | AstraZeneca AB (SE) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010053438-A1 | MODULATORS OF AMYLOID BETA. | ASTRAZENECA AB (SE) | 2010-05-14 | — | — | WO | disclosed |